Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth

Cancer tissues are composed of cancer cells and the surrounding stromal cells (e.g., fibroblasts, vascular endothelial cells, and immune cells), in addition to the extracellular matrix. Most studies investigating carcinogenesis and the progression, invasion, metastasis, and angiogenesis of cancer have focused on alterations in cancer cells, including genetic and epigenetic changes. Recently, interactions between cancer cells and the stroma have attracted considerable attention, and increasing evidence has accumulated on this. Several researchers have gradually clarified the origins, features, and roles of cancer-associated fibroblasts (CAFs), a major component of the cancer stroma. CAFs function in a similar manner to myofibroblasts during wound healing. We previously reported the relationship between CAFs and angiogenesis. Interleukin-6 (IL-6), a multifunctional cytokine, plays a central role in regulating inflammatory and immune responses, and important roles in the progression, including proliferation, migration, and angiogenesis, of several cancers. We showed that CAFs are an important IL-6 source and that anti-IL-6 receptor antibody suppressed angiogenesis and inhibited tumor-stroma interactions. Furthermore, CAFs contribute to drug-resistance acquisition in cancer cells. The interaction between cancer cells and the stroma could be a potential target for anti-cancer therapy.

[1]  H. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. , 1986, The New England journal of medicine.

[2]  S. Ghatak,et al.  Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan* , 2003, Journal of Biological Chemistry.

[3]  E. Lengyel,et al.  MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer. , 2012, Cancer discovery.

[4]  Robert A. Weinberg,et al.  Heterogeneity of stromal fibroblasts in tumor , 2007 .

[5]  Lena Claesson-Welsh,et al.  Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. , 2006, Experimental cell research.

[6]  R. Swann,et al.  Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy , 2013, Clinical Cancer Research.

[7]  F. Strutz,et al.  Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.

[8]  A. G. de Herreros,et al.  LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival , 2015, Clinical Cancer Research.

[9]  R. Sikes,et al.  Insidious Changes in Stromal Matrix Fuel Cancer Progression , 2014, Molecular Cancer Research.

[10]  A. Larue,et al.  Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment. , 2015, World journal of stem cells.

[11]  K. Oda,et al.  Matrix Metalloproteinase (MMP)-9 in Cancer-Associated Fibroblasts (CAFs) Is Suppressed by Omega-3 Polyunsaturated Fatty Acids In Vitro and In Vivo , 2014, PloS one.

[12]  P. Ji,et al.  Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastasis and prognosis in colorectal cancer , 2011, Medical oncology.

[13]  E. Raymond,et al.  Targeting cancer cell metabolism in pancreatic adenocarcinoma , 2015, Oncotarget.

[14]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[15]  R. Markwald,et al.  Sturctural analysis of endocardial cytodifferentiation. , 1975, Developmental biology.

[16]  M. Vaccaro,et al.  Autophagy, Warburg, and Warburg Reverse Effects in Human Cancer , 2014, BioMed research international.

[17]  M. Hatano,et al.  DA-Raf-Mediated Suppression of the Ras—ERK Pathway Is Essential for TGF-β1-Induced Epithelial—Mesenchymal Transition in Alveolar Epithelial Type 2 Cells , 2015, PloS one.

[18]  C. Bucana,et al.  Expression of activated platelet‐derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential , 2006, International journal of cancer.

[19]  C. López-Otín,et al.  Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). , 1997, European journal of biochemistry.

[20]  T. Golub,et al.  Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion , 2012, Nature.

[21]  Jiwang Zhang,et al.  Osteopontin Mediates an MZF1-TGF-β1-Dependent Transformation of Mesenchymal Stem Cells into Cancer Associated Fibroblasts in Breast Cancer , 2014, Oncogene.

[22]  Philip Levy Ho,et al.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.

[23]  C. Heldin,et al.  Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. , 2001, Cancer research.

[24]  R. Kalluri,et al.  Mechanisms of metastasis: Epithelial‐to‐mesenchymal transition and contribution of tumor microenvironment , 2007, Journal of cellular biochemistry.

[25]  Lianyu Chen,et al.  Chinese Herbal Medicine Suppresses Invasion-Promoting Capacity of Cancer-Associated Fibroblasts in Pancreatic Cancer , 2014, PloS one.

[26]  Hiroyuki Tomita,et al.  Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. , 2011, Cancer cell.

[27]  M. Fukayama,et al.  Periostin Is Expressed in Pericryptal Fibroblasts and Cancer-associated Fibroblasts in the Colon , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  E. Giannoni,et al.  Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression , 2014, Oncogene.

[29]  R. Weinberg,et al.  Heterogeneity of stromal fibroblasts in tumors. , 2007, Cancer biology & therapy.

[30]  M. Loeffler,et al.  Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake. , 2006, The Journal of clinical investigation.

[31]  G. Kroemer,et al.  Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells , 2012, Cell Death and Disease.

[32]  J. Bouchal,et al.  The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance , 2014, Cancer Cell International.

[33]  Jinxiang Tan,et al.  Adipocyte is a non-trivial, dynamic partner of breast cancer cells. , 2011, The International journal of developmental biology.

[34]  Olivier De Wever,et al.  Cancer-Associated Fibroblasts Connect Metastasis-Promoting Communication in Colorectal Cancer , 2015, Front. Oncol..

[35]  R. Bhatia,et al.  Stem Cell Quiescence , 2011, Clinical Cancer Research.

[36]  A. Molinolo,et al.  Carcinoma‐associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF‐2/FGFR‐2 axis , 2008, International journal of cancer.

[37]  K. Smalley,et al.  Fibroblast-mediated drug resistance in cancer. , 2013, Biochemical pharmacology.

[38]  J. Rubin,et al.  Characterization of Transplanted Green Fluorescent Protein+ Bone Marrow Cells into Adipose Tissue , 2008, Stem cells.

[39]  E. Hay,et al.  Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells , 1982, The Journal of cell biology.

[40]  A. Larue,et al.  Hematopoietic origin of fibroblasts/myofibroblasts: Its pathophysiologic implications. , 2006, Blood.

[41]  B. Curti Physical barriers to drug delivery in tumors. , 1993, Critical reviews in oncology/hematology.

[42]  M. Dewhirst,et al.  Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-β and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation , 2006, British Journal of Cancer.

[43]  Malte Buchholz,et al.  Stromal biology and therapy in pancreatic cancer , 2010, Gut.

[44]  E. Motrescu,et al.  Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle , 2008, Biological chemistry.

[45]  E. Giannoni,et al.  Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells , 2013, Cell cycle.

[46]  H. Takeyama,et al.  Relationship between inflammation and cancer progression: Recent advances in interleukin-6 signaling and its blockage in cancer therapy , 2014 .

[47]  J. Wang,et al.  IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer , 2014, Oncogene.

[48]  G. Fan,et al.  Cancer-Associated Fibroblasts in a Human HEp-2 Established Laryngeal Xenografted Tumor Are Not Derived from Cancer Cells through Epithelial-Mesenchymal Transition, Phenotypically Activated but Karyotypically Normal , 2015, PloS one.

[49]  B. Teicher,et al.  Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo. , 1990, Science.

[50]  I. Ben-Sahra,et al.  Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? , 2010, Molecular Cancer Therapeutics.

[51]  F. Sotgia,et al.  Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors , 2010, Cell cycle.

[52]  T. Sjöblom,et al.  STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer. , 2013, Cancer research.

[53]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[54]  Xueli Yuan,et al.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis , 2007, Nature Medicine.

[55]  Lei Mu,et al.  Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer , 2015, PloS one.

[56]  R. Kalluri,et al.  The role of endothelial-to-mesenchymal transition in cancer progression , 2008, British Journal of Cancer.

[57]  Chen Li-rong,et al.  Overexpression of caveolin-1 in cancer-associated fibroblasts predicts good outcome in breast cancer. , 2012, Breast care.

[58]  S. Eccles,et al.  Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells , 2014, BMC Cancer.

[59]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[60]  Douglas B. Evans,et al.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression. , 2008, Cancer research.

[61]  Donald R Schwartz,et al.  Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. , 2003, Cancer cell.

[62]  Ming Liu,et al.  Effects of cancer-associated fibroblasts on the migration and invasion abilities of SGC-7901 gastric cancer cells , 2012, Oncology letters.

[63]  A. Molinolo,et al.  Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth , 2010, BMC Cancer.

[64]  J. Wang,et al.  IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer. , 2014, Oncogene.

[65]  Kunwei Shen,et al.  Stromal cells in tumor microenvironment and breast cancer , 2012, Cancer and Metastasis Reviews.

[66]  Robert A. Weinberg,et al.  Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.

[67]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[68]  N. Asai,et al.  Akt-Girdin signaling in cancer-associated fibroblasts contributes to tumor progression. , 2015, Cancer Research.

[69]  Tong-Cun Zhang,et al.  The role of endothelial–mesenchymal transition in development and pathological process , 2012, IUBMB life.

[70]  S. Yeh,et al.  BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts , 2015, International journal of oncology.

[71]  A. Larue,et al.  Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin. , 2012, International journal of clinical and experimental pathology.

[72]  L. Fabris,et al.  Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumor-stroma interactions. , 2013, Oncology reports.

[73]  W. Schürch,et al.  Smooth‐muscle differentiation in stromal cells of malignant and non‐malignant breast tissues , 1988, International journal of cancer.

[74]  A. Roberts,et al.  Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-α and TGF-β , 2005, Journal of Cell Science.

[75]  B. Hennessy,et al.  Adipose tissue derived stem cells differentiate into carcinoma-associated fibroblast-like cells under the influence of tumor derived factors , 2011, Cellular Oncology.

[76]  E. Itoi,et al.  Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours , 2009, Histopathology.

[77]  A. Aboussekhra,et al.  Caffeine Mediates Sustained Inactivation of Breast Cancer-Associated Myofibroblasts via Up-Regulation of Tumor Suppressor Genes , 2014, PloS one.

[78]  J. Houghton,et al.  Tumor microenvironment: The role of the tumor stroma in cancer , 2007, Journal of cellular biochemistry.

[79]  A. Geinoz,et al.  The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1 , 1998, Journal of Cell Biology.

[80]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[81]  Mikinori Sato,et al.  Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction , 2013, British Journal of Cancer.

[82]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[83]  K. Chayama,et al.  Anti‐stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model , 2011, International journal of cancer.

[84]  J. Park,et al.  Fibroblast Activation Protein, a Dual Specificity Serine Protease Expressed in Reactive Human Tumor Stromal Fibroblasts* , 1999, The Journal of Biological Chemistry.

[85]  L. Xiao,et al.  The cancer-associated fibroblasts and drug resistance. , 2015, European review for medical and pharmacological sciences.

[86]  K. Sukhdeo,et al.  Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A , 2013, The Journal of experimental medicine.

[87]  C. Tiribelli,et al.  The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis , 2015, BMC Cancer.

[88]  A. Jungbluth,et al.  Expression and role of the cell surface protease seprase/fibroblast activation protein-α (FAP-α) in astroglial tumors , 2011, Biological chemistry.

[89]  M. Mizumoto,et al.  Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. , 1998, British Journal of Cancer.

[90]  Olivier De Wever,et al.  Stromal myofibroblasts are drivers of invasive cancer growth , 2008, International journal of cancer.

[91]  R. Lin,et al.  Rapamycin and mTOR kinase inhibitors , 2008, Journal of chemical biology.

[92]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[93]  R. Kalluri,et al.  The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis. , 2011, Genes & cancer.

[94]  J. Reid,et al.  A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer , 2015, BMC Cancer.

[95]  Li Yang,et al.  Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells , 2015, Breast Cancer Research.

[96]  A. Orimo,et al.  Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target , 2013, Cancers.

[97]  F. Jerhammar,et al.  Cancer-Associated Fibroblasts Induce Matrix Metalloproteinase–Mediated Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cells , 2012, Molecular Cancer Research.

[98]  Liang Xie,et al.  Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.

[99]  J. Bruun,et al.  Cancer-Associated Fibroblasts from Lung Tumors Maintain Their Immunosuppressive Abilities after High-Dose Irradiation , 2015, Front. Oncol..

[100]  M. Kudo,et al.  Signaling Pathways Governing Tumor Angiogenesis , 2011, Oncology.

[101]  P. Hahnfeldt,et al.  Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. , 1994, Cancer research.

[102]  O. De Wever,et al.  Differential secretome analysis of cancer‐associated fibroblasts and bone marrow‐derived precursors to identify microenvironmental regulators of colon cancer progression , 2013, Proteomics.

[103]  T. Ochiya,et al.  Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. , 2003, Biochemical and biophysical research communications.

[104]  Mark W. Kieran,et al.  Identification of fibroblast heterogeneity in the tumor microenvironment , 2006, Cancer biology & therapy.

[105]  Yihai Cao,et al.  R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways , 2008, Journal of Molecular Medicine.

[106]  W. Cavenee,et al.  Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. , 1999, Cancer research.

[107]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[108]  Toshimichi Yoshida,et al.  Tenascin-C and integrins in cancer , 2015, Cell adhesion & migration.

[109]  R. Palmqvist,et al.  High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis , 2013, Tumor Biology.

[110]  M. Papi,et al.  Epithelial-Stromal Interactions in Human Breast Cancer: Effects on Adhesion, Plasma Membrane Fluidity and Migration Speed and Directness , 2012, PloS one.

[111]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[112]  Fei Xing,et al.  Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.

[113]  Yu Zhao,et al.  Prognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis. , 2015, International journal of clinical and experimental medicine.

[114]  James O. Jones,et al.  Suppression of Antitumor Immunity by Stromal Cells Expressing , 2022 .

[115]  T. Hunt,et al.  Bone Marrow Contribution to Tumor-Associated Myofibroblasts and Fibroblasts , 2004, Cancer Research.

[116]  A. Vincent-Salomon,et al.  Oxidative stress promotes myofibroblast differentiation and tumour spreading , 2010, EMBO molecular medicine.

[117]  B. Chauffert,et al.  In vivo and in vitro invasiveness of a rat colon‐cancer cell line maintaining E‐cadherin expression: An enhancing role of tumor‐associated myofibroblasts , 1994, International journal of cancer.

[118]  Robert A. Gatenby,et al.  Environment-mediated drug resistance: a major contributor to minimal residual disease , 2009, Nature Reviews Cancer.

[119]  Rakesh K. Jain,et al.  Vascular and interstitial barriers to delivery of therapeutic agents in tumors , 1990, Cancer and Metastasis Reviews.

[120]  W. Dalton,et al.  Mechanisms Associated with cell Adhesion Mediated Drug Resistance (CAM-DR) in Hematopoietic Malignancies , 2004, Cancer and Metastasis Reviews.

[121]  Tobias Sjöblom,et al.  Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. , 2002, Cancer research.

[122]  M. Bissell,et al.  The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion , 2001, Breast Cancer Research.